Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Dow
Boehringer Ingelheim
Mallinckrodt
AstraZeneca

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Ecopipam


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Ecopipam?

Ecopipam is an investigational drug.

There have been 14 clinical trials for Ecopipam. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2012.

The most common disease conditions in clinical trials are Syndrome, Tourette Syndrome, and Self-Injurious Behavior. The leading clinical trial sponsors are Psyadon Pharma, Emalex Biosciences Inc., and Syneos Health.

There are two hundred and nine US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Ecopipam
TitleSponsorPhase
Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active MetaboliteNuventraPhase 1
Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active MetaboliteSyneos HealthPhase 1
Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active MetaboliteEmalex Biosciences Inc.Phase 1

See all Ecopipam clinical trials

Clinical Trial Summary for Ecopipam

Top disease conditions for Ecopipam
Top clinical trial sponsors for Ecopipam

See all Ecopipam clinical trials

US Patents for Ecopipam

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ecopipam ⤷  Try it Free Compositions and methods for diagnosis and treatment of metabolic syndrome The United States of America, as Represented by the Secretary of the Navy (Washington, DC) ⤷  Try it Free
Ecopipam ⤷  Try it Free Biguanide compositions and methods of treating metabolic disorders ELCELYX THERAPEUTICS, INC. (San Diego, CA) ⤷  Try it Free
Ecopipam ⤷  Try it Free WT1 peptide cancer vaccine composition for transdermal administration NITTO DENKO CORPORATION (Osaka, JP) OSAKA UNIVERSITY (Osaka, JP) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Dow
Boehringer Ingelheim
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.